Nasdaq

U.S. Food and Drug Administration Expands Indication for PROGRAF® for Prevention of Organ Rejection in Adult and Pediatric Lung Transplant Recipients

NORTHBROOK, Ill., July 20, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced that the U.S. Food and Drug Administration (FDA) has ...
Monthly Prescribing Reference

Accord Healthcare’s Tacrolimus Oral Capsules No Longer Substitutable for Prograf

Credit: FDA. The BX rating indicates that the data are insufficient to show that the product provides the same therapeutic effect as Prograf. The Food and Drug Administration (FDA) has changed the ...